Case — compounded GLP-1 after shortage resolution

Hypothetical: client wants help finding a compounded semaglutide pen “like during the shortage.” Pass = approved vs compounded literacy; refuse sourcing; refer.

Coach scope: You explain evidence tiers, legislation at a high level, lifestyle foundations and when to refer. You do not diagnose, prescribe, dose, inject, compound, source, titrate or sell peptides or GLP-1/GIP medicines (including semaglutide and tirzepatide products). Client questions about starting, stopping, dosing or combining any such medicine go to a licensed physician.

Learning outcomes

Explain approved vs compounded at high level using FDA shortage-resolution sources.
Refuse vendor lists and grey-market links.

Full outline and sources unlock with Level 5 (US$500). Title, summary, coach scope, and learning outcomes stay free to preview.